サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1663439

デジタル乳房トモシンセシスの世界市場：製品別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Digital Breast Tomosynthesis Market, By Product, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 391 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
デジタル乳房トモシンセシスの世界市場：製品別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年01月04日
発行: AnalystView Market Insights
ページ情報: 英文 391 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

デジタル乳房トモシンセシスの市場規模は、2024年に28億1,450万米ドルとなり、2025年から2032年にかけてCAGR 14.20%で拡大

デジタル乳房トモシンセシスの市場力学

乳がんの有病率の上昇

市場拡大の主な要因の1つは、世界の乳がん罹患率の上昇です。世界保健機関は、2020年に230万人の女性が乳がんの診断を受け、世界全体で685万人がこの病気で死亡すると推定しています。2020年末までに、過去5年間に乳がんと診断された女性は780万人に上り、世界で最も頻度の高いがんとなっています。デジタル乳房トモシンセシスと呼ばれるプロセスを用いることで、乳房組織を3次元的に再構成し、乳房全体を連続した部分として見ることができます。これにより、乳がんの同定率を高めながら、偽陽性率やリコール率を下げることができます。さらに、乳管に限局した小さな異常組織の増殖である乳管がん (DCIS) の同定も容易になります。デジタル乳房トモシンセシス産業は、これらの腫瘍が早期に除去されれば患者に害を及ぼすことはほとんどないという事実によって牽引されています。

デジタル乳房トモシンセシス市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間 (2025～2032年) に約14.20%のCAGRで毎年成長すると推定されています。

製品別では、スタンドアロン3Dシステムは2024年に最大市場シェアを示すと予測されました。

最終用途別では、病院が2024年の主要セグメントでした。

地域別では、北米が2024年に収益を上げる主要市場です。

デジタル乳房トモシンセシス市場：セグメンテーション分析

デジタル乳房トモシンセシスの世界市場は、製品、最終用途、地域に基づいてセグメント化されます。

製品別では、市場はスタンドアロン3Dシステムと2D/3Dコンビネーションシステムに分別されます。2024年には、使いやすい機能、病変の可視化の強化、正確な検出結果をもたらす技術開発により、スタンドアロン3Dシステムが市場を席巻します。さらに、デジタル乳房トモシンセシスは乳房の完全な画像化を提供し、特に乳腺組織が密な場合の早期発見に役立ちます。視認性を高め、正確な早期発見を容易にするために、3次元画像技術を利用しています。その結果、医療施設でのDBTの使用が市場拡大を刺激しています。例えば、2023年6月現在、FDA認証を取得している米国マンモグラフィセンターの約87%が、少なくとも1台のDBTシステムを導入しています。

最終用途に基づき、市場は病院、診療所、診断センター、その他に分けられます。2024年には、病院カテゴリーが圧倒的な市場シェアを占めています。医療施設が充実している病院では、診断能力を向上させるためにDBTのような最先端のイメージング技術に対するニーズが高いです。乳がんやその他の異常の早期診断は、DBTの臨床現場へのイントロダクションよって可能になった乳房組織のより精密で詳細な画像化によって促進されます。DBT装置の必要性は、病院が多くの患者集団にサービスを提供することが多いという事実によって、さらに高まっています。病院は引き続きDBTの導入と実装を主導しており、診断センターや他の医療施設でもこの技術が使用されているにもかかわらず、DBT装置市場で最大のエンドユーザー部門となっています。

デジタル乳房トモシンセシス市場：地域別分析

2024年、北米はデジタル乳房トモシンセシスの世界市場で支配的な地位を占めています。これは、乳がん罹患率の上昇と、この分野における主要な業界参加者の存在の両方と関連付けることができます。例えば、米国がん協会によると、2023年には約190万人ががんの診断を受けた。さらに、この地域の市場が成長しているのは、早期がん診断施設だけでなく、技術的な飛躍的進歩や研究開発を提供する高度な医療インフラの存在が大きいです。また、乳がんに対する国民の意識向上を目的とした政府のプログラム、資金提供、投資も、予測期間中の市場成長に寄与すると予想されます。

しかし、予測期間を通じてCAGRが最も速いと予想されるのは欧州地域です。これは、この地域の高齢者数の増加や最近の技術開発動向によるものです。がん罹患率の上昇、医療施設の充実、研究開発の重視も市場開拓に影響を与えています。例えば、欧州乳がん連合 (EUROPA DONNA) は、2022年にはWHO欧州地域の女性の16%が乳がんで死亡すると報告しています。この分野におけるDBTの実施も、早期発見に対する一般市民の意識を高める取り組みや医療プログラムの結果として増加しています。乳がん生存者を支援し、早期発見と質の高いケアへのタイムリーなアクセスの価値を強調するために、ARENAはKeep A Breast Foundationと提携して乳がん啓発コレクションを開始しました。

デジタル乳房トモシンセシス市場：競合情勢

デジタル乳房トモシンセシス市場は非常に競争が激しく、GEヘルスケア、アナロジック・コーポレーション、トリビトロン・ヘルスケア、シーメンス・ヘルティニアーズ、ホロジック・インク、その他の大手競合企業が戦略的イニシアチブを積極的に推進し、市場の覇権を争っています。競争力を得るため、これらの企業は新製品の開発、技術の向上、製品ラインの多様化に注力しています。提供する製品を改善し、持続可能性、性能、効率の面で変化する顧客の要求に応えるため、これらの企業は常に研究開発に投資しています。例えば、2024年7月、米国で食品医薬品局から販売承認を受けたばかりの新しい21HQ613D-B診断モニターにより、LGエレクトロニクス (LG) はB2B医療機器市場で事業を拡大しています。

最近の動向

2023年1月Blackford Analysis Ltd.は、放射線科医の不足と医療用画像のニーズの高まりを解決するため、バイエルに買収されました。基本的には、臨床ワークフローにおけるAIの活用を通じて放射線医学のイノベーションを促進することで、患者の生活の質を高めることです。

2023年1月乳がんに対する英国初の陽子線治療試験がユニバーシティ・カレッジ・ロンドン病院 (UCLH) によって開始されます。この試験により、放射線治療ビームをより正確に照射できるようになり、主に生涯にわたる心臓障害のリスクがある患者が対象となります。陽子線治療は、心臓へのオフターゲット放射線を低下させるだけでなく、乳房組織に適切な放射線量を集中的に照射するのに役立ちます。

2022年8月：Whiterabbit社が、3Dマンモグラフィとして知られるデジタル乳房トモシンセシス画像を解析し、乳がんの自動診断に役立てるACTプログラムを発表。

2022年 5月：Therapixel社が米国での商業的プレゼンスを拡大するため、シリーズ Bの資金調達で1,500万ユーロを獲得。さらに、この資金調達により、マンモグラフィ読影支援の機能を拡張し、MammoScreenプラットフォームの新機能の開発を可能にします。

目次

第1章 デジタル乳房トモシンセシス市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 デジタル乳房トモシンセシスの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 デジタル乳房トモシンセシス市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 デジタル乳房トモシンセシス市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 デジタル乳房トモシンセシスの市場情勢

  • デジタル乳房トモシンセシスの市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 デジタル乳房トモシンセシス市場：製品別

  • 概要
    • セグメント別シェア分析：製品別
    • スタンドアロン3Dシステム
    • 2D/3D複合システム

第8章 デジタル乳房トモシンセシス市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 病院
    • 診療所
    • 診断センター
    • その他

第9章 デジタル乳房トモシンセシス市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析：デジタル乳房トモシンセシス業界

  • 競合ダッシュボード
  • 企業プロファイル
    • GE Healthcare
    • Analogic Corporation
    • Trivitron Healthcare
    • Siemens Healthineers
    • Hologic Inc.
    • General Electric Company
    • Internazionale Medico Scientifica
    • Canon Medical
    • FUJIFILM Holdings Corporation
    • PLANMED OY
    • Others

第11章 アナリストの全方位展望

目次
Product Code: ANV4621

REPORT HIGHLIGHT

Digital Breast Tomosynthesis Market size was valued at US$ 2,814.5 Million in 2024, expanding at a CAGR of 14.20% from 2025 to 2032.

Digital breast tomosynthesis, sometimes referred to as 3D mammography, is a very successful technique for identifying breast cancer, especially in dense breast tissue. Unlike normal mammography, which uses 2D images, digital breast tomosynthesis uses a succession of 2D photos to build a 3D image. Using an X-ray tube, digital breast tomosynthesis (DBT) creates several 2D images of the breast from various perspectives. This procedure is comparable to a typical mammography, except that the breast is squeezed and positioned in an arc. Following digitization, the pictures are fused to create a three-dimensional image (three-dimensional) that offers more detailed information and facilitates the differentiation of potentially malignant tissue from healthy tissue. By providing a more precise and thorough image of the breast, this technique improves the diagnostic potential of breast cancer screening. Due to increased knowledge of the advantages of digital breast tomosynthesis (DBT) equipment for breast cancer screening, such as improved diagnostic accuracy and decreased recall rates, the market for this technology is expanding quickly. Technological breakthroughs like greater 3D imaging and software improvements for higher-quality images are also driving this growth. The need for DBT equipment is also being driven by the rising incidence of breast cancer, especially in women 40 years of age and older. The efforts of healthcare institutions and the government to promote early identification of breast cancer are also fueling the market's growth.

Digital Breast Tomosynthesis Market- Market Dynamics

Rising Prevalence of Breast Cancer

One of the main factors propelling the market's expansion is the increasing incidence of breast cancer worldwide. The World Health Organization estimates that 2.3 million women received a breast cancer diagnosis in 2020, and 6,85,000 people died from the disease globally. By the end of 2020, 7.8 million women had been diagnosed with breast cancer in the past five years, making it the most frequent cancer worldwide. Through the use of a process called digital breast tomosynthesis, breast tissue can be reconstructed in three dimensions and viewed as successive parts throughout the breast. It reduces the false-positive or recall rate while increasing the identification of breast cancer. Additionally, it makes ductal carcinoma in situ (DCIS), which are tiny, aberrant tissue growths that are limited to the breast's milk ducts, easier to identify. The digital breast tomosynthesis industry is driven by the fact that these tumours rarely cause harm to the patient if removed early.

Digital Breast Tomosynthesis Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.20% over the forecast period (2025-2032)

Based on product segmentation, the standalone 3D systems were predicted to show maximum market share in the year 2024

Based on end use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Digital Breast Tomosynthesis Market- Segmentation Analysis:

The Global Digital Breast Tomosynthesis Market is segmented on the basis of Product, End Use, and Region.

On the basis of product, the market is segregated into Standalone 3D Systems and 2D/3D Combination Systems. In 2024, the market was dominated by the standalone 3D systems category ascribed to the device's easy-to-use features, enhanced lesion visualization, and technical developments that produce accurate detection results. Furthermore, digital breast tomosynthesis provides thorough imaging of the breast, which helps with early detection, particularly in cases of dense breast tissue. In order to enhance visibility and facilitate precise early detection, it makes use of three-dimensional imaging techniques. As a result, the use of DBT in healthcare facilities has stimulated market expansion. For instance, approximately 87% of U.S. mammography centres with FDA certification had at least one DBT system in place as of June 2023.

Based on end use, the market is divided into Hospitals, Clinics, Diagnostics Centers, and Others. In 2024, the hospitals category held a dominant market share. Hospitals with extensive medical facilities show a high need for cutting-edge imaging technologies, such as DBT, to improve their diagnostic capacities. Early diagnosis of breast cancer and other abnormalities is facilitated by the more precise and detailed imaging of breast tissue made possible by the introduction of DBT into clinical settings. The need for DBT equipment is further increased by the fact that hospitals frequently serve a sizable patient population. Hospitals continue to lead the adoption and implementation of DBT, making them the largest end-user sector in the DBT equipment market, even though diagnostic centres and other healthcare facilities also use this technology.

Digital Breast Tomosynthesis Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Digital Breast Tomosynthesis. It can be linked to both the rising incidence of breast cancer and the existence of major industry participants in this area. In 2023, for instance, approximately 1.9 million people received a cancer diagnosis, according to the American Cancer Society. Additionally, the region's market is growing due in large part to the sophisticated healthcare infrastructure that offers early cancer diagnosis facilities as well as technical breakthroughs and research and development. The government's programs, funding, and investments aimed at raising public awareness of breast cancer are also anticipated to contribute to the market's growth over the forecast period.

However, throughout the projected period, the Europe region is anticipated to see the fastest CAGR. This is explained by the growing number of older adults in this area as well as recent developments in technology. The rising incidence of cancer, better medical facilities, and an emphasis on research and development have also influenced the market's expansion. For instance, the European Breast Cancer Coalition, or EUROPA DONNA, reports that 16% of women in the WHO Europe Region died from breast cancer in 2022. The implementation of DBT in this area has also increased as a result of initiatives and healthcare programs that have raised public awareness of early identification. In order to help breast cancer survivors and emphasize the value of early detection and timely access to high-quality care, ARENA started a breast cancer awareness collection in partnership with the Keep A Breast Foundation.

Digital Breast Tomosynthesis Market- Competitive Landscape:

The market for digital breast tomosynthesis is extremely competitive, with a number of major competitors such as GE Healthcare, Analogic Corporation, Trivitron Healthcare, Siemens Healthineers, Hologic Inc. and others actively pursuing strategic initiatives and fighting for market dominance. To obtain a competitive edge, these businesses concentrate on developing new products, improving technology, and diversifying their product lines. In order to improve their product offerings and meet the changing demands of their clientele in terms of sustainability, performance, and efficiency, these businesses consistently invest in research and development. For instance, in July 2024, with the new 21HQ613D-B diagnostic monitor, which was just approved for sale in the United States by the Food and Drug Administration, LG Electronics (LG) is growing its business in the B2B medical device market.

Recent Development

January 2023: Blackford Analysis Ltd. was acquired by Bayer in order to solve the shortage of radiologists and the growing need for medical imaging. Basically, it's to enhance the quality of life for patients by promoting innovation in radiology through the use of AI in clinical workflow.

January 2023: The first UK proton beam therapy trial for breast cancer was started by University College London Hospitals (UCLH). This trial will allow radiotherapy beams to be aimed more precisely, primarily at patients who are at risk for lifelong cardiac problems. In addition to lowering off-target radiation to the heart, proton beam therapy will assist in concentrating on radiation doses that are appropriate for breast tissue.

August 2022: Whiterabbit introduced its ACT program, which uses digital breast tomosynthesis images, also known as 3D mammograms, to analyze them and help diagnose breast cancer automatically.

May 2022: Therapixel obtained EUR 15 million in Series B fundraising to expand its commercial presence in the US. Additionally, the financing will help expand the capabilities of its mammography reading assistance and enable the development of new features for its MammoScreen platform.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GE Healthcare
  • Analogic Corporation
  • Trivitron Healthcare
  • Siemens Healthineers
  • Hologic Inc.
  • General Electric Company
  • Internazionale Medico Scientifica
  • Canon Medical
  • FUJIFILM Holdings Corporation
  • PLANMED OY
  • Others

GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Standalone 3D Systems
  • 2D/3D Combination Systems

GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Diagnostics Centers
  • Others

GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Digital Breast Tomosynthesis Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Digital Breast Tomosynthesis Market Snippet by Product
    • 2.1.2. Digital Breast Tomosynthesis Market Snippet by End Use
    • 2.1.3. Digital Breast Tomosynthesis Market Snippet by Country
    • 2.1.4. Digital Breast Tomosynthesis Market Snippet by Region
  • 2.2. Competitive Insights

3. Digital Breast Tomosynthesis Key Market Trends

  • 3.1. Digital Breast Tomosynthesis Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Digital Breast Tomosynthesis Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Digital Breast Tomosynthesis Market Opportunities
  • 3.4. Digital Breast Tomosynthesis Market Future Trends

4. Digital Breast Tomosynthesis Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Digital Breast Tomosynthesis Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Digital Breast Tomosynthesis Market Landscape

  • 6.1. Digital Breast Tomosynthesis Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Digital Breast Tomosynthesis Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Standalone 3D Systems
    • 7.1.3. 2D/3D Combination Systems

8. Digital Breast Tomosynthesis Market - By End Use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Clinics
    • 8.1.4. Diagnostics Centers
    • 8.1.5. Others

9. Digital Breast Tomosynthesis Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Digital Breast Tomosynthesis Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Digital Breast Tomosynthesis Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Digital Breast Tomosynthesis Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Digital Breast Tomosynthesis Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Digital Breast Tomosynthesis Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Digital Breast Tomosynthesis Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. GE Healthcare
    • 10.2.2. Analogic Corporation
    • 10.2.3. Trivitron Healthcare
    • 10.2.4. Siemens Healthineers
    • 10.2.5. Hologic Inc.
    • 10.2.6. General Electric Company
    • 10.2.7. Internazionale Medico Scientifica
    • 10.2.8. Canon Medical
    • 10.2.9. FUJIFILM Holdings Corporation
    • 10.2.10. PLANMED OY
    • 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us